Glucosaminyl N-deacetylase mRNA expression in diabetic rats

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 7, 1999, Pages 453-456

  Oturai, P ^a,b   Deckert, M ^a   Rolin, B ^a   Jensen, T ^a   Kofoed Enevoldsen, A ^a  

^a STENO DIABETES CENTER   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Experimental diabetes; Heparan sulphate; N deacetylase; Streptozotocin diabetic rat

Indexed keywords

ACYLTRANSFERASE; CYCLOPHILIN; GLUCOSAMINYL DEACETYLASE; GLUCOSE; HEPARAN SULFATE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; MALE; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; SYNTHESIS;

EID: 0032753698     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212137     Document Type: Article

References (16)

1. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590-596, 1985
2. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
3. Danielson PE, Forss-Petter S, Brow MA, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG: plB15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7: 261-267, 1988
4. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A: Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-226, 1989
5. Deckert T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T: Microalbuminuria - implications for micro-and macrovascular disease. Diabetes Care 15: 1181-1191, 1992
6. Eriksson I, Sandbäck D, Ek B, Lindahl U, Kjellén L: cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin. J Biol Chem 269: 10438-10443, 1994
7. Ferré F, Marchese A, Pezzoli P, Griffin S, Buxton E, Boyer V: Quantitative PCR: an overview. In: Mullis KB, Ferré F, Gibbs RA (eds.). The Polymerase Chain Reaction, pp. 67-88, Birkhauser, Boston, 1994
8. Hashimoto Y, Orellana A, Gil G, Hirschberg CB: Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase. J Biol Chem 267: 15744-15750, 1992
9. Kofoed-Enevoldsen A: Inhibition of glomerular glucosaminyl N-deacetylase in diabetic rats. Kidn Int 41: 763-767, 1992
10. Kofoed-Enevoldsen A, Eriksson UJ: Inhibition of N-acetylheparosan deacetylase in diabetic rats. Diabetes 40: 1449-1452, 1991
11. Kofoed-Enevoldsen A, Noonan D, Deckert T: Diabetes-mellitus induced-inhibition of glucosaminyl n-deacetylase - effect of short-term blood-glucose control in diabetic rats. Diabetologia 36: 310-315, 1993
12. Lindahl U, Lidholt K, Spillmann D, Kjellen L: More to heparin than anticoagulation. Thrombosis Research 75: 1-32, 1994
13. Mauer SM: Structural-functional correlations of diabetic nephropathy. Kidn Int 45: 612-622, 1994
14. Navia JL, Riesenfeld J, Vann WF, Lindahl U, Rodén L: Assay of N-acetylheparosan deacetylase with a capsular polysaccharide from Escherichia coli K5 as substrate. Anal Biochern 135: 134-140, 1983
15. Olgemoller B, Schleicher E: Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy. Clin Invest 71: S13-S19, 1993
16. Unger E, Pettersson I, Eriksson UJ, Eindahl U, Kjellén L: Decreased activity of the heparan sulfate-modifying enzyme glucosaminyl N-deacetylase in hepatocytes from streptozotocin-diabetic rats. J Biol Chem 266: 8671-8674, 1991